Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to the artificially low, government-set prices in other developed nations.

In a move he called “one of the most consequential executive orders in U.S. history,” President Donald Trump recently ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

The companies’ new effort would bypass traditional middlemen to cut the drug’s monthly cost from a list price of around $606 ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

Adam Colborn, JD, associate vice president of congressional affairs at AMCP, shares insights on the impact of the Most ...

Missourians simply cannot afford their prescription drugs. More than one in four have skipped doses or split pills to make prescriptions last longer. Over half worry they won’t be able to afford their ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

President Donald Trump’s executive order to limit pharmaceutical prices is a mistake. To the extent that it succeeds in lowering drug costs for Americans, it will endanger the next generation of ...

Earlier this week, President Donald Trump issued an executive order giving "most favored nation" status to the United States when it comes to pharmaceutical prices. Trump’s order pushes ...